The appearance of the cervix can change in normal pregnancy. Features can include an increase in cervical size, a bluish appearance due to increase vascularity. These physiological changes may appear suspicious to an inexperienced clinician (2).
Most cervical abnormalities are benign and patients can be reassured and managed conservatively. Some changes are described below.
- Cervical ectopy – most common benign abnormality and may be associated with increased physiological discharge, no further investigation required.
- Nabothian Follicles/Cysts – normal finding in women of childbearing age
- Cervicitis/inflammation of the cervix – this can be acute or chronic and are most likely associated with Sexually Transmitted Infections (HSV, chlamydia, gonnorrhoea, trichomonas). Screening with appropriate swabs should be undertaken.
- Condyloma (genital warts) - may be present in remainder of genital tract including vagina and vulva.
Cervical Polyp –They can be found in up to 4% of women, and are commonly asymptomatic. However, in pregnancy they may present with vaginal bleeding or antepartum haemorrhage. They can be ectocervical, endocervical or endometrial in origin.
Risk of malignancy is low estimated at <0.1% in the pre-menopausal woman (3). If there is clinical concern that the polyp may be atypical and/or previous unresolved abnormal cervical cytology, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted. This should be an urgently dictated letter, which is sent to colposcopy via Scottish Care Information gateway (SCI-gateway) referral pathway by the transcribing secretary.
All patients with cervical polyps, irrespective of antenatal management should be reviewed in postnatally (obstetrics or general gynaecology) at 6-12 weeks. This should be highlighted via Alert tab in Badger, and referral made using a dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.
Suspicious cervical mass - cervical carcinoma is rare in pregnancy with estimated prevalence 1-10/10 000 pregnancies (2).
If malignancy is suspected on clinical examination in a stable patient, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted. This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.